We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAVI:NASDAQNavient Corporation Analysis

Data as of 2026-05-26 - not real-time

$8.58

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Navient trades just below its 20‑day SMA and above its 50‑day SMA, with a neutral RSI around 52 and a marginally bullish MACD histogram, suggesting short‑term price stability near the $7.88 support level and well below the $9.84 resistance. The stock carries an extremely high dividend yield of 7.6% but a payout ratio of 200%, making the dividend financially unsustainable given negative earnings, zero free cash flow, and a debt‑to‑equity ratio near 1900. Recent Q1 results showed a 22% revenue decline yet a GAAP profit beat, and the board announced a leadership transition, adding both a catalyst and uncertainty. Valuation metrics (forward PE ~9 versus industry ~17 and price‑to‑book ~0.34) indicate the stock is priced well below fundamentals, but the massive leverage and regulatory exposure in the student‑loan sector temper upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near technical support with neutral momentum
  • Recent earnings beat but unsustainable dividend payout
  • Decreasing volume suggesting limited short‑term buying pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Heavy debt load and low free cash flow constrain operational flexibility
  • Leadership transition could improve execution or add uncertainty
  • Forward earnings estimate offers modest upside relative to current price

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Extremely high leverage and potential regulatory reforms in student‑loan servicing
  • Valuation discount to book value provides a margin of safety if restructuring succeeds
  • Sustained dividend at current payout ratio is unlikely, impacting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-0.80%
Profit Margin-18.54%
P/E Ratio9.1
ROE-2.46%
ROA-0.12%
Debt/Equity1900.00
P/B Ratio0.3
Op. Cash Flow$323.0M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI51.8
Support$7.88
Resistance$9.84
MA 20$8.60
MA 50$8.48
MA 200$11.07
MACDBullish
VolumeDecreasing
Fear & Greed Index91.3

Valuation

Target Price$9.44
Upside/Downside9.99%
GradeUndervalued
TypeValue
Dividend Yield7.60%

Risk Assessment

Beta0.83
Volatility36.64%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.